Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liquidation
Biotech
Asarina to close after efforts to partner Tourette's drug fail
After reaching out to more than 200 companies to partner a Tourette syndrome therapy, Asarina Pharma has come up empty and will fold.
Annalee Armstrong
Jul 24, 2024 10:32am
SQZ opts for liquidation, $11.8M asset fire sale to Stemcell
Mar 1, 2024 10:20am
The unraveling of EQRx's low-cost drug dream
Oct 5, 2023 10:47am
Fresh Tracks to dissolve after hunt for buyer comes up empty
Sep 19, 2023 5:37pm
Cash-strapped Calithera closes down in wake of enrollment delays
Jan 10, 2023 8:05am